Application 210393
- Type
- ANDA
- Sponsor
- GLENMARK PHARMS LTD
Application Products#
Product, Drug, Ingredient table| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|
| 001 | TACROLIMUS | TACROLIMUS | OINTMENT;TOPICAL | 0.1% | No | No |
| 002 | TACROLIMUS | TACROLIMUS | OINTMENT;TOPICAL | 0.03% | No | No |
NDC Listings For This Application#
NDC, Name, Nonproprietary name table| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|
| 68462-534 | Tacrolimus | Tacrolimus | Glenmark Pharmaceuticals Inc., USA | ANDA | Current |
| 68462-534 | Tacrolimus | Tacrolimus | Glenmark Pharmaceuticals Inc., USA | ANDA | Current |
| 68462-534 | Tacrolimus | Tacrolimus | Glenmark Pharmaceuticals Inc., USA | ANDA | Current |